Michael Agrez

2.1k total citations
66 papers, 1.8k citations indexed

About

Michael Agrez is a scholar working on Immunology and Allergy, Oncology and Cancer Research. According to data from OpenAlex, Michael Agrez has authored 66 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology and Allergy, 21 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Michael Agrez's work include Cell Adhesion Molecules Research (24 papers), Protease and Inhibitor Mechanisms (14 papers) and Cellular Mechanics and Interactions (6 papers). Michael Agrez is often cited by papers focused on Cell Adhesion Molecules Research (24 papers), Protease and Inhibitor Mechanisms (14 papers) and Cellular Mechanics and Interactions (6 papers). Michael Agrez collaborates with scholars based in Australia, United States and China. Michael Agrez's co-authors include Dean Sheppard, Richard C. Bates, Jun Niu, Robert Pytela, Ric I. Cone, Andrew Chen, Gordon F. Burns, Darren R. Shafren, Richard D. Barry and Xinhua Gu and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Biomaterials.

In The Last Decade

Michael Agrez

65 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Agrez Australia 22 770 587 510 421 280 66 1.8k
O Schiraldi Italy 18 513 0.7× 615 1.0× 482 0.9× 652 1.5× 101 0.4× 75 2.1k
Theodore E. Maione United States 16 341 0.4× 1.1k 1.8× 498 1.0× 228 0.5× 76 0.3× 26 1.9k
T K Kishimoto United States 18 1.6k 2.1× 656 1.1× 272 0.5× 289 0.7× 90 0.3× 23 2.4k
Sachiko Seo Japan 26 234 0.3× 1.0k 1.7× 527 1.0× 185 0.4× 122 0.4× 74 2.9k
DF Mosher United States 14 506 0.7× 341 0.6× 91 0.2× 387 0.9× 65 0.2× 20 1.5k
R A Warnock United States 11 1.9k 2.5× 756 1.3× 538 1.1× 266 0.6× 75 0.3× 12 3.2k
Ari Tuuttila Finland 14 189 0.2× 421 0.7× 468 0.9× 820 1.9× 84 0.3× 14 1.4k
Felipe Andrade United States 26 267 0.3× 828 1.4× 299 0.6× 203 0.5× 183 0.7× 56 2.9k
Gijs A. van Seventer United States 24 1.3k 1.6× 594 1.0× 396 0.8× 165 0.4× 118 0.4× 37 3.1k
Yoji Sasahara Japan 22 354 0.5× 446 0.8× 260 0.5× 76 0.2× 341 1.2× 103 1.9k

Countries citing papers authored by Michael Agrez

Since Specialization
Citations

This map shows the geographic impact of Michael Agrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Agrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Agrez more than expected).

Fields of papers citing papers by Michael Agrez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Agrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Agrez. The network helps show where Michael Agrez may publish in the future.

Co-authorship network of co-authors of Michael Agrez

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Agrez. A scholar is included among the top collaborators of Michael Agrez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Agrez. Michael Agrez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Howard, Christopher B., Pie Huda, Nicholas L. Fletcher, et al.. (2025). Immune-modulating nanomedicines for enhanced drug delivery to non-small-cell lung cancer. Biomaterials. 317. 123089–123089. 1 indexed citations
2.
Agrez, Michael, Mark S. Rybchyn, Rebecca S. Mason, et al.. (2023). An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage. Scientific Reports. 13(1). 11702–11702. 3 indexed citations
3.
Agrez, Michael, Christopher Chandler, Kristofer J. Thurecht, et al.. (2023). An immunomodulating peptide with potential to suppress tumour growth and autoimmunity. Scientific Reports. 13(1). 19741–19741.
4.
Agrez, Michael, Justyna Rzepecka, Christopher Chandler, et al.. (2022). A novel lipidic peptide with potential to promote balanced effector-regulatory T cell responses. Scientific Reports. 12(1). 11185–11185. 4 indexed citations
5.
Agrez, Michael, Manohar L. Garg, & Stephen P. Ackland. (2012). Novel Anti-Cancer Peptides Comprising Three Amino Acids. Journal of Cancer Therapy. 3(4). 230–236. 1 indexed citations
6.
Ahmed, Nuzhat, Padma Murthi, Michael Quinn, et al.. (2002). Overexpression of αvβ6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis. 23(2). 237–244. 111 indexed citations
7.
Sanson‐Fisher, Rob, Isobel Rolfe, Peter Jones, Clare Ringland, & Michael Agrez. (2002). Trialling a new way to learn clinical skills: systematic clinical appraisal and learning. Medical Education. 36(11). 1028–1034. 14 indexed citations
8.
Agrez, Michael, et al.. (1998). MANAGEMENT OF SIGMOID COLON INTUSSUSCEPTION PRESENTING THROUGH THE ANUS. Australian and New Zealand Journal of Surgery. 68(9). 683–685. 7 indexed citations
9.
Agrez, Michael, Darren R. Shafren, Xinhua Gu, et al.. (1997). Integrin αvβ6 Enhances Coxsackievirus B1 Lytic Infection of Human Colon Cancer Cells. Virology. 239(1). 71–77. 31 indexed citations
10.
Huang, Xiaozhu, Andrew Chen, Michael Agrez, & Dean Sheppard. (1995). A Point Mutation in the Integrin β6 Subunit Abolishes Both α v β6 Binding to Fibronectin and Receptor Localization to Focal Contacts. American Journal of Respiratory Cell and Molecular Biology. 13(2). 245–251. 14 indexed citations
11.
Agrez, Michael, Cliff Meldrum, Alistair T.R. Sim, et al.. (1995). A Fibroblast Elongation Factor Purified from Colon Carcinoma Cells Shares Sequence Identity with TIMP-1. Biochemical and Biophysical Research Communications. 206(2). 590–600. 10 indexed citations
12.
Agrez, Michael & Richard C. Bates. (1994). Colorectal cancer and the integrin family of cell adhesion receptors: Current status and future directions. European Journal of Cancer. 30(14). 2166–2170. 29 indexed citations
13.
Tooney, Paul A., Michael Agrez, & Gordon F. Burns. (1993). A re‐examination of the molecular basis of cell movement. Immunology and Cell Biology. 71(2). 131–139. 12 indexed citations
14.
Agrez, Michael, et al.. (1992). CHANGING TRENDS IN PERFORATED PEPTIC ULCER DURING THE PAST 45 YEARS. Australian and New Zealand Journal of Surgery. 62(9). 729–732. 13 indexed citations
15.
Agrez, Michael, S. Redman, Rob Sanson‐Fisher, & Deborah Hennrikus. (1990). FEASIBILITY OF SIGMOIDOSCOPIC SCREENING FOR COLORECTAL CANCER IN THE HUNTER REGION. Australian and New Zealand Journal of Surgery. 60(2). 87–92. 13 indexed citations
16.
Agrez, Michael, David M. Evans, & John M. Duggan. (1990). FAECAL OCCULT BLOOD TESTING FOR COLORECTAL CANCER: LUXURY OR NECESSITY?. Australian and New Zealand Journal of Surgery. 60(6). 451–454. 3 indexed citations
17.
Agrez, Michael, et al.. (1990). AORTO‐GASTRIC FISTULA FOLLOWING NISSEN FUNDOPLICATION. Australian and New Zealand Journal of Surgery. 60(10). 823–825. 6 indexed citations
18.
Bowen, K. M., et al.. (1989). The use of collagen gel to deplete fetal rat pancreas cell suspensions of nonendocrine cells.. PubMed. 21(5). 3809–10. 2 indexed citations
19.
Agrez, Michael. (1989). HUMAN COLON CANCER AND FIBROBLAST CELL LINES CULTURED IN AND ON COLLAGEN GELS. Australian and New Zealand Journal of Surgery. 59(5). 415–420. 7 indexed citations
20.
Agrez, Michael, et al.. (1982). Metachronous colorectal malignancies. Diseases of the Colon & Rectum. 25(6). 569–574. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O Schiraldi Breakdown of academic impact, for papers by Theodore E. Maione Breakdown of academic impact, for papers by T K Kishimoto Breakdown of academic impact, for papers by Sachiko Seo Breakdown of academic impact, for papers by DF Mosher Breakdown of academic impact, for papers by R A Warnock Breakdown of academic impact, for papers by Ari Tuuttila Breakdown of academic impact, for papers by Felipe Andrade Breakdown of academic impact, for papers by Gijs A. van Seventer Breakdown of academic impact, for papers by Yoji Sasahara
Rankless by CCL
2026